comparemela.com
Home
Live Updates
CG Pharmaceuticals Prepares to Showcase Its Ongoing Phase 2 Study for Ivaltinostat in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) : comparemela.com
CG Pharmaceuticals Prepares to Showcase Its Ongoing Phase 2 Study for Ivaltinostat in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
/PRNewswire/ -- CG Pharmaceuticals, a company dedicated to advancing innovative therapies to improve the lives of patients with cancer, prepares to showcase...
Related Keywords
Anna Berkenblit ,
Prnewswire Cg Pharmaceuticals ,
Pancreatic Cancer Action Network Pan ,
Cg Pharmaceuticals Contact ,
Mcg Pharmaceuticals ,
Source Cg Pharmaceuticals Inc ,
Chief Scientific ,
Medical Officer ,
Pancreatic Cancer Action Network ,
Looking Statement Disclosure ,
comparemela.com © 2020. All Rights Reserved.